Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Many Approved Drugs Have Bioactive Analogs With Different Target Annotations
by
Lounkine, Eugen
, Bajorath, Jürgen
, Hu, Ye
in
Annotations
/ Drugs
/ Hypotheses
/ Kinases
2014
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Many Approved Drugs Have Bioactive Analogs With Different Target Annotations
by
Lounkine, Eugen
, Bajorath, Jürgen
, Hu, Ye
in
Annotations
/ Drugs
/ Hypotheses
/ Kinases
2014
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Many Approved Drugs Have Bioactive Analogs With Different Target Annotations
Journal Article
Many Approved Drugs Have Bioactive Analogs With Different Target Annotations
2014
Request Book From Autostore
and Choose the Collection Method
Overview
Close structural relationships between approved drugs and bioactive compounds were systematically assessed using matched molecular pairs. For structural analogs of drugs, target information was assembled from ChEMBL and compared to drug targets reported in DrugBank. For many drugs, multiple analogs were identified that were active against different targets. Some of these additional targets were closely related to known drug targets while others were not. Surprising discrepancies between reported drug targets and targets of close structural analogs were often observed. On one hand, the results suggest that hypotheses concerning alternative drug targets can often be formulated on the basis of close structural relationships to bioactive compounds that are easily detectable. It is conceivable that such obvious structure–target relationships are frequently not considered (or might be overlooked) when compounds are developed with a focus on a primary target and a few related (or undesired) ones. On the other hand, our findings also raise questions concerning database content and drug repositioning efforts.
Publisher
Springer Nature B.V
Subject
This website uses cookies to ensure you get the best experience on our website.